News for Karuna Therapeutics, Inc. (KRTX.MX)

Advancements and Projections in the Pharmaceutical Intermediates Market: Insights, Trends, Opportunities, and Recent Developments...

PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share

Insight into the Fund's Latest Investment Decisions and Stock Adjustments Vanguard Health Care Fund (Trades, Portfolio), managed by Wellington Management Compan

Bristol-Myers Squibb Company (NYSE: BMY) reported an adjusted loss per share of $4.40, narrower than the Zacks Consensus Estimate of a loss of $4.53 per share. In the year-ago quarter, BMY posted adjusted earnings per share of $2.05.

Bristol Myers Squibb's market capitalization has declined significantly due to the impending expiration of patents for its flagship drugs. Learn more on BMY stock here.

Biotech M&A activity surged at the end of 2023, which helped small biotech sector surge. Find out 3 logical buyout targets in biotech/biopharma space in 2024.

Karuna Therapeutics, Inc. dropped from S&P Biotechnology Select Industry Index...

In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.

Karuna Therapeutics set to merge with Bristol-Myers Squibb

Karuna Therapeutics Inc (KRTX), a clinical-stage biopharmaceutical company focused on developing novel therapies for neuropsychiatric disorders, has reported an

BALA CYNWYD, Pa., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

NEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Vanguard Health Care Fund VGHCX portfolio, holdings, 13f and stock news. Updated: 2023-05-01 portfolio, holdings, 13F and news. Updated: 2023-05-01

Sign up for our FREE Newsletter and get: The Beginner’s Handbook For…

In this piece, we will take a look at the twelve best stocks that have recently had their initial public offering.

Three clinical-stage, wholly-owned candidates being advanced across range of indications, including two Phase 2 trials of LYT-100 , a Phase 1/2 trial of LYT-200 and a Phase 1 study of LYT-300 Key... | December 16, 2021

GuruFocus Article or News written by insider and the topic is about: